NEOGENOMICS INC — Director's Dealing 2016

Sep 16, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2016-09-14

Reporting Person: JONES STEVEN C (Executive VP of Finance)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-09-14	Warrants	$1.50	S	225000	Disposed	2017-05-03	Common Stock (225000)	Direct
2016-09-14	Warrants	$1.50	S	112500	Disposed	2017-05-03	Common Stock (112500)	Direct
2016-09-14	Warrants	$1.50	S	112500	Disposed	2017-05-03	Common Stock (112500)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3150000	Indirect
Common Stock	266251	Direct
Common Stock	50476	Indirect
Common Stock	52157	Indirect
Common Stock	190000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$4.78	2020-05-04	Common Stock (225000)	225000	Direct
Stock Option (Right to Buy)	$7.15	2021-04-20	Common Stock (100000)	100000	Direct

Footnotes

F1: Aspen Select Healthcare, LP is a private investment fund. Medical
Venture Partners, LLC is the sole general partner of Aspen Select Healthcare, LP, and Mr. Jones is a Managing Member of Medical Venture Partners, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.

F2: On May 4, 2015, Mr. Jones was granted 225,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.

F3: On April 20, 2016, Mr. Jones was granted 100,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F4: Warrants were sold to an unaffiliated third party and remain subject to exercise.

F5: Such warrants were issued in connection with a consulting agreement, dated 5/3/2010.